definiens: means [ … * * * … ] collectively referred to herein as a ), providedthat the term NANOBODY PRODUCT shall not include any NANOBODY that specifically binds to asingle therapeutic target wherein said therapeutic target is Receptor Activator of Nuclear FactorKappa_B Ligand ( ), [ … * * * … ] . For the sake of clarity, a NANOBODY PRODUCT containingthe same NANOBODY active ingredient(s ) as another NANOBODY PRODUCT is nevertheless aseparate and distinct NANOBODY PRODUCT from such other NANOBODY PRODUCT page 1 of 24 date : 28/08/2017CONFIDENTIAL TREATMENT REQUESTED . INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HASBEEN REQUESTED IS OMITTED AND MARKED WITH . AN UNREDACTED VERSION OF THEDOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGECOMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED